Bide Pharmatech (SH:688073) Ge Long Hui A P P·2025-09-12 11:09Core Viewpoint - Bid Pharma (688073.SH) announced a share reduction plan by several shareholders due to their liquidity needs, with a total reduction not exceeding 1.00% of the company's total share capital [1] Shareholder Reduction Details - Shareholder Li Yijing plans to reduce up to 227,854 shares, representing 0.25% of the total share capital [1] - Shareholder Chen Jun plans to reduce up to 136,395 shares, representing 0.15% of the total share capital [1] - Shareholder Li Li plans to reduce up to 136,395 shares, representing 0.15% of the total share capital [1] - Shareholder Du Juan plans to reduce up to 136,395 shares, representing 0.15% of the total share capital [1] - Shareholder Li Aifei plans to reduce up to 131,836 shares, representing 0.15% of the total share capital [1] - Shareholder Geng Yong plans to reduce up to 91,265 shares, representing 0.10% of the total share capital [1] - Shareholder Jiang Yamei plans to reduce up to 47,960 shares, representing 0.05% of the total share capital [1] Implementation Timeline - The reduction will occur within three months starting from three trading days after the announcement of the reduction plan, with prices determined by market conditions at the time of the reduction [1]